Investor Relations

Corporate Governance

Albany Molecular Research Inc.’s (AMRI) success has been built on a reputation for the highest quality standards in its work and ethics. Its corporate governance structure demonstrates AMRI’s commitment to maintaining these standards.

Below is a summary of AMRI’s Board Committees, which includes membership and charter information. Additional Corporate Governance information is available by clicking on the links in the side navigation.

Board Committees

Board of Directors
Thomas D’Ambra, Ph.D., Chairman of the Board
David Deming
Kenneth Hagen
Gerardo Gutiérrez
Anthony Maddaluna
Fernando Napolitano
William Marth
Kevin O’Connor
Arthur Roth
Una S. Ryan, Ph.D.
Lori Henderson, Secretary

Audit Committee
Kenneth P. Hagen, CPA, Chair
David Deming
Anthony Maddaluna
Arthur Roth

Compensation Committee
David H. Deming, Chair
Ken Hagen
Kevin O’Connor
Una S. Ryan, Ph.D.

Nominating and Corporate Governance Committee
Kevin O’Connor, Chair
Fernando Napolitano
Anthony Maddaluna
Arthur Roth
Una S. Ryan, Ph.D.